You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》美銀證券降阿里健康(00241.HK)目標價至6.4元 反映人幣貶值
美銀證券發表報告指,近期與阿里健康(00241.HK)管理層舉行投資者會議。公司向主要股東阿里巴巴(09988.HK)收購醫療營銷業務,有助公司提供一站式解決方案,更好回應健康護理商戶的需求、提升商戶的推廣效益。在2023財年,目標業務的稅前盈利12億元人民幣,管理層表明會將大部分盈利重新投資,在未來幾年爭取更大市場份額,同時保障整體盈利有理想增長。 報告指,阿里健康2024年度上半年盈利好過市場預期,維持下半年度收入按年增長13%的預測,增幅與上半年度相同,並輕微上調下半年度純利預測至5.2億元人民幣,按年增長40%,主要因為利潤率較高的非藥物產品供應量提升,維持其「買入」評級,反映客戶購買頻率增加、以及健康護理開支提升,支持網上滲透率提升,目標價由7元下調至6.4元,則反映人民幣貶值的因素。(cy/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account